Clinical Trial Detail

NCT ID NCT03458728
Title Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Bayer
Indications

Ewing sarcoma

lymphoma

Advanced Solid Tumor

neuroblastoma

rhabdomyosarcoma

osteosarcoma

Therapies

Copanlisib

Age Groups: child adult

No variant requirements are available.